Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ProPhotonix Receives $1.1 million Order

15th Jun 2016 07:00

RNS Number : 1921B
ProPhotonix Limited
15 June 2016
 

 

June 15, 2016

 

ProPhotonix Limited

("ProPhotonix" or the "Company")

 

ProPhotonix Receives $1.1 million Order

 

ProPhotonix Limited, (London Stock Exchange - AIM: PPIX and OTC: STKR) today announces the receipt of a $1.1 million order for laser modules from one of its largest customers. Deliveries for this order are currently scheduled for the remainder of 2016 and early 2017.

 

Commenting on the order, Jeremy Lane, Managing Director of ProPhotonix Limited, laser business unit said, "We are delighted to receive this order from our customer. We have been collaborating with them on this product design for their application for more than a year, and this order represents a joint success for both of our companies. Production fulfilment for this customer began at the end of 2015 and has ramped up dramatically."

 

 

 

Enquiries:

ProPhotonix Limited

Tim Losik, President and CEO

 

Tel: +1 603 893 8778

[email protected]

Stockdale Securities Limited

Tom Griffiths/David Coaten

Tel: +44 (0) 20 7601 6100

Nominated Adviser and Broker

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio (formerly Oclaro), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com

 

Cautionary Statement 

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

######

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUUAQUPQGAC

Related Shares:

PPIX.L
FTSE 100 Latest
Value8,275.66
Change0.00